Robert Negrin, MD is a professor of medicine and former Chief of the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. He received his undergraduate degree from the University of California at Berkeley and MD from Harvard Medical School. He trained in Internal Medicine and Hematology at Stanford University and joined the faculty at Stanford University in 1990.

His research focuses on developing a more fundamental understanding of immune mediated reactions such as graft vs host and graft vs tumor reactions with a particular interest in immune regulatory mechanisms. Several concepts developed in his laboratory have been translated to clinical trials including the concept developed by Orca Bio. Dr. Negrin has published over 300 manuscripts and 44 book chapters. He has won a number of awards including fellowships from the Damon Runyon Walter Winchell Cancer Fund and the Jose Carreras International Leukemia Foundation. He was a recipient of a Distinguished Clinical Science Award from the Doris Duke Foundation. He received the E. Donnall Thomas lectureship and Lifetime Achievement Award from ASTCT and the Mechtild Harf Award from the DKMS. He is an elected member of the Association of American Physicians.

Dr. Negrin has served on multiple editorial boards and was an Associate Editor of Blood and the Founding Editor in Chief at Blood Advances. He has served as the President of the International Society of Cellular Therapy, the American Society of Blood and Marrow Transplantation (currently American Society of Transplantation and Cellular Therapy) and is currently the President of the American Society of Hematology. He is a frequent volunteer with CHPAA and participated in over 8 Missions.